Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: A case report with autopsy examination
- 1 February 2000
- journal article
- case report
- Published by Elsevier in Human Pathology
- Vol. 31 (2) , 250-253
- https://doi.org/10.1016/s0046-8177(00)80229-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- An Autopsy Case of Troglitazone-Induced Fulminant HepatitisDiabetes Care, 1998
- Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case ReportAnnals of Internal Medicine, 1998
- Hepatic Dysfunction Associated with TroglitazoneNew England Journal of Medicine, 1998
- A Novel Antidiabetic Drug, Troglitazone — Reason for Hope and ConcernNew England Journal of Medicine, 1998
- Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Troglitazone (CS-045): A New Antidiabetic AgentHormone and Metabolic Research, 1997
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patientsDiabetologia, 1996